Prismic Pharmaceuticals

About:

Prismic Pharmaceuticals is focused on developing novel prescription medical drugs for the treatment of inflammatory diseases.

Website: http://www.prismicpharma.com

Description:

Prismic Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on developing novel prescription medical foods for the clinical dietary management of the metabolic processes associated with disorders commonly seen in the aging “baby boomer” population. These include disorders of the central nervous system (CNS), as well as conditions where inflammation is an underlying or significant cause of the disorder.. The company's initial product candidates are focused on the use of a highly purified form of Omega-3 fatty acids in combination with other molecules for the treatment of CNS disorders, and are protected by a series of issued U.S. and foreign composition and use patents.

Total Funding Amount:

$1.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Scottsdale, Arizona, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)prismicpharma.com

Founders:

Peter Moriarty, Zachary Dutton

Number of Employees:

11-50

Last Funding Date:

2013-02-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai